Home Coronavirus COVID-19 US: Monoclonal Antibody Drug with Promise Against Omicron Gets Emergency Authorization Coronavirus COVID-19Government-ServicesNational-International-Beyond US: Monoclonal Antibody Drug with Promise Against Omicron Gets Emergency Authorization February 12, 2022 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password
